No harm from angiotensin-converting enzyme inhibitors or angiotensin receptor inhibitors in patients with COVID-19. Results of a prospective study on a hospital-based cohort. Italian Journal of Medicine, v. 14, n. 3, p. 162–166, 18 Sep.2020.